The study of practical application of the Mindlessness Scale
Not Applicable
- Conditions
- Depression,Anxiety Disorders
- Registration Number
- JPRN-UMIN000025743
- Lead Sponsor
- Kobe Gakuin univ.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
The acute phase Maladjustment to the group
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method the Mindlessness Scale
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What neurobiological pathways are associated with mindfulness-based interventions in JPRN-UMIN000025743 for depression and anxiety disorders?
How does the Mindlessness Scale compare to CBT and SSRIs in treating depression and anxiety disorders according to JPRN-UMIN000025743?
What psychological biomarkers predict response to the Mindlessness Scale in JPRN-UMIN000025743 for major depressive disorder and generalized anxiety disorder?
What are the potential adverse effects of the Mindlessness Scale in JPRN-UMIN000025743 and how are they managed in clinical practice?
Are there combination therapies with the Mindlessness Scale and pharmacological agents in JPRN-UMIN000025743 for treatment-resistant depression and anxiety disorders?